XML 85 R72.htm IDEA: XBRL DOCUMENT v3.25.3
Segment Reporting - Reconciliation of Financial Measures of Segments to Consolidated Totals (Details)
$ in Millions
 1 Months Ended 3 Months Ended 9 Months Ended
Sep. 22, 2025
USD ($)
Jun. 30, 2025
client
Sep. 30, 2025
USD ($)
Jun. 30, 2025
USD ($)
Mar. 31, 2025
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2025
USD ($)
claim
Sep. 30, 2024
USD ($)
Segment Reporting Information [Line Items]                
Revenues from external customers     $ 102,239     $ 94,878 $ 294,735 $ 273,701
Net investment income (loss)     632     550 1,639 1,398
Total revenues     102,871     95,428 296,374 275,099
Less: Net realized capital gains (losses)     (11)     19 (59) (89)
Cost of products sold     57,045     52,948 162,107 151,019
Health care costs     32,020     29,922 92,472 85,578
Reconciliation of principal measure of segment performance to consolidated operating loss:                
Amortization of intangible assets     500     507 1,493 1,522
Net realized capital losses (gains)     11     (19) 59 89
Acquisition-related transaction and integration costs     27     41 100 203
Goodwill impairment     5,725     0 5,725 0
Health Care Delivery clinic closure charge     83       83  
Litigation charges     320         100
Office real estate optimization charges           17 10 17
Restructuring charges     0     1,169 0 1,169
Loss on Accountable Care assets             288  
Operating income (loss)     (3,207)     832 2,548 6,148
Gain on deconsolidation of subsidiary $ 483   483     0 483 0
Interest expense     (784)     (752) (2,332) (2,200)
Other income     26     25 83 74
Income (loss) before income tax provision     (3,482)     105 782 4,022
Depreciation and amortization     1,134     1,161 $ 3,459 3,450
Number of claims for which litigation charges were recorded | claim             2  
Opioid Litigation                
Reconciliation of principal measure of segment performance to consolidated operating loss:                
Litigation charges             $ 320  
Legacy Litigation                
Reconciliation of principal measure of segment performance to consolidated operating loss:                
Litigation charges             1,220  
U.S. ex rel. Bassan et al. v. Omnicare, Inc. and CVS Health Corp.                
Reconciliation of principal measure of segment performance to consolidated operating loss:                
Litigation charges       $ 542 $ 387      
United States Ex Rel. Behnke v. CVS Caremark Corporation, Et Al.                
Reconciliation of principal measure of segment performance to consolidated operating loss:                
Litigation charges       $ 291        
Number of clients | client   2            
Health Care Benefits                
Segment Reporting Information [Line Items]                
Revenues from external customers     35,431     32,555 105,667 96,577
Net investment income (loss)     513     423 1,307 1,076
Reconciliation of principal measure of segment performance to consolidated operating loss:                
Goodwill impairment             0  
Depreciation and amortization     375     407 1,199 1,196
Health Services                
Segment Reporting Information [Line Items]                
Revenues from external customers     42,354     40,794 120,568 115,954
Net investment income (loss)     (1)     (1) 10 (3)
Reconciliation of principal measure of segment performance to consolidated operating loss:                
Goodwill impairment             5,725  
Loss on Accountable Care assets             288  
Depreciation and amortization     260     267 781 792
Pharmacy & Consumer Wellness                
Segment Reporting Information [Line Items]                
Revenues from external customers     24,441     21,515 68,460 61,127
Net investment income (loss)     0     0 0 0
Reconciliation of principal measure of segment performance to consolidated operating loss:                
Goodwill impairment             0  
Depreciation and amortization     396     387 1,169 1,164
Corporate/ Other                
Segment Reporting Information [Line Items]                
Revenues from external customers     13     14 40 43
Net investment income (loss)     120     128 322 325
Reconciliation of principal measure of segment performance to consolidated operating loss:                
Depreciation and amortization     103     100 310 298
Intersegment Eliminations                
Segment Reporting Information [Line Items]                
Net investment income (loss)     0     0 0 0
Total revenues     (18,735)     (14,262) (51,937) (40,547)
Intersegment Eliminations | Health Care Benefits                
Segment Reporting Information [Line Items]                
Total revenues     (49)     (18) (87) (54)
Intersegment Eliminations | Health Services                
Segment Reporting Information [Line Items]                
Total revenues     (6,913)     (3,336) (18,603) (10,634)
Intersegment Eliminations | Pharmacy & Consumer Wellness                
Segment Reporting Information [Line Items]                
Total revenues     (11,773)     (10,908) (33,247) (29,859)
Operating Segments and Corporate/ Other                
Segment Reporting Information [Line Items]                
Total revenues     121,606     109,690 348,311 315,646
Adjusted operating income (loss)     3,459     2,547 11,846 9,248
Operating Segments | Health Care Benefits                
Segment Reporting Information [Line Items]                
Net investment income (loss)     513     423 1,307 1,076
Total revenues     35,993     32,996 107,061 97,707
Less: Net realized capital gains (losses)     33     (1) (1) (82)
Cost of products sold     0     0 0 0
Health care costs     31,319     29,443 90,696 84,359
Other segment items     4,327     4,478 12,751 12,684
Adjusted operating income (loss)     314     (924) 3,615 746
Reconciliation of principal measure of segment performance to consolidated operating loss:                
Net realized capital losses (gains)     (33)     1 1 82
Operating Segments | Health Services                
Segment Reporting Information [Line Items]                
Net investment income (loss)     (1)     (1) 10 (3)
Total revenues     49,266     44,129 139,181 126,585
Less: Net realized capital gains (losses)     0     0 15 0
Cost of products sold     45,230     40,381 128,425 116,678
Health care costs     1,291     936 3,439 2,428
Other segment items     695     608 2,074 1,997
Adjusted operating income (loss)     2,050     2,204 5,228 5,482
Reconciliation of principal measure of segment performance to consolidated operating loss:                
Net realized capital losses (gains)     0     0 (15) 0
Co-payments     2,400     2,700 8,800 8,900
Operating Segments | Pharmacy & Consumer Wellness                
Segment Reporting Information [Line Items]                
Net investment income (loss)     0     0 0 0
Total revenues     36,214     32,423 101,707 90,986
Less: Net realized capital gains (losses)     0     0 0 0
Cost of products sold     29,647     26,032 83,005 72,627
Health care costs     0     0 0 0
Other segment items     5,089     4,795 14,573 14,343
Adjusted operating income (loss)     1,478     1,596 4,129 4,016
Reconciliation of principal measure of segment performance to consolidated operating loss:                
Net realized capital losses (gains)     0     0 0 0
Corporate/ Other | Corporate/ Other                
Segment Reporting Information [Line Items]                
Net investment income (loss)     120     128 322 325
Total revenues     133     142 362 368
Less: Net realized capital gains (losses)     (44)     20 (73) (7)
Cost of products sold     0     0 0 0
Health care costs     47     49 133 142
Other segment items     513     402 1,428 1,229
Adjusted operating income (loss)     (383)     (329) (1,126) (996)
Reconciliation of principal measure of segment performance to consolidated operating loss:                
Net realized capital losses (gains)     $ 44     $ (20) $ 73 $ 7